Struggling to stay afloat, toy maker Jakks Pacific turned to an unexpected lifeline: its intellectual property. By pledging licensing rights as collateral, the company unlocked critical financing to extend its survival. This move highlights a powerful trend—IP isn’t just a legal safeguard; it’s a valuable asset that can secure both equity and debt deals.

Why IP Matters in Capital Raising

For many companies—especially startups and innovators—traditional financing options like unsecured bank loans or venture capital are either too expensive or unavailable. Intellectual property changes that equation. When structured properly, IP can become the foundation for raising capital, whether through equity or debt.

Equity investors see value when intellectual property is central to the company’s growth strategy and backed by licensing deals that prove commercial traction. Debt providers, on the other hand, look for predictable royalty cash flows or licensing agreements that can serve as collateral. In both cases, IP transforms from an intangible concept into a tangible financial asset.

Equity Deals Backed by IP

Equity financing often relies on intellectual property to boost a company’s valuation. A patent portfolio, a set of trademarks, or proprietary technology with licensing potential signals a defendable competitive advantage.

Real-world example: In 2016, Snap Inc. (Snapchat’s parent company) highlighted its IP assets—including design patents, software, and trademarks—as a core driver of its IPO valuation. While not a licensing deal itself, the company’s ability to license technology and content partnerships was a key part of investor confidence.

For smaller firms, equity deals often come through hybrid licensing agreements, where an investor receives both a stake in the company and rights to sublicense the IP. This dual structure gives investors both ownership upside and immediate IP-driven revenue opportunities.

Debt Financing Through IP Collateral

Debt financing is more direct: lenders provide capital today in exchange for rights to future IP cash flows or a security interest in the IP itself.

Example: In 2014, biotech company NantKwest secured a $75 million credit facility backed by its IP portfolio. The loan allowed NantKwest to fund ongoing research and clinical development without diluting ownership, while lenders gained confidence from the company’s patents and licensing potential.

This type of financing is not limited to biotech. Media companies, consumer brands, and software firms have leveraged trademarks, copyrights, and licensing contracts to access credit. The critical factor is whether the licensing agreements are structured in a way that guarantees enforceable, predictable revenue.

Structuring IP-Secured Deals

Both equity and debt deals require licensing contracts that meet investor and lender expectations. That means:

• Clearly defined, enforceable royalty terms with unambiguous payment schedules.
• Robust audit rights that provide transparency and accountability.
• Termination protections that mitigate sudden loss of value.
• Recorded security interests in the IP to give lenders priority and confidence.

Without these protections, IP-backed financing is viewed as speculative, and terms will either be unfavorable or unattainable.

When Is IP Ready for Equity or Debt Funding?

Funders look for more than just patents or pending applications. They want evidence that the IP produces (or will imminently produce) revenue:

• Signed licensing agreements generating royalty streams.
• Clear proof of market adoption or commercial traction.
• A pipeline of opportunities for sublicensing or expansion.

In short, your IP must already demonstrate its ability to produce revenue. An unlicensed patent might hold promise, but until it’s validated in the marketplace, most funders will not view it as a bankable asset.

The Bigger Picture

Equity and debt financing secured by IP offer a powerful alternative to traditional capital raising. Equity deals leverage IP to increase valuation and attract investors. Debt deals transform licensing revenues into collateral that opens doors to credit facilities. Both approaches require well-structured licensing agreements and proof of commercial traction.